Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial
PaperCitations, authors & open-access status
Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 229 citations, 2021 year and closed oa status.
229
Citations
2021
Year
closed
OA Status